sulfamethoxypyridazine has been researched along with Heart Failure in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parsons, V | 1 |
Porter, A | 1 |
Dische, F | 1 |
1 other study available for sulfamethoxypyridazine and Heart Failure
Article | Year |
---|---|
Cardiomyopathy and renal failure occurring in the puerperium.
Topics: Acute Kidney Injury; Adult; Bacillus; Bacteriuria; Connective Tissue; Drug Hypersensitivity; Female; | 1971 |